Skip to main content
NewslettersWatchlist

Spectral Medical Inc(EDT-T)
TSX

Today's Change
Real-Time Last Update
Day Low0.50
Day High0.52
Open:0.52
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
GlobeNewswire
Spectral Medical Announces Third Quarter Results and Provides Corporate Update
GlobeNewswire
Spectral Medical Provides October Tigris Trial Update
GlobeNewswire
Spectral Medical Provides September Tigris Trial Update
GlobeNewswire
Spectral Medical Provides August Tigris Trial Update
GlobeNewswire
Spectral Medical Announces Second Quarter Results and Provides Corporate Update
AllPennyStocks.com
Sepsis Trial Update Sending Shares of this Medical Device Maker Higher
GlobeNewswire
Spectral Medical Provides July Tigris Trial Update
GlobeNewswire
Spectral Medical Inc. Announces Closing of Additional US$1 Million Convertible Notes
GlobeNewswire
Spectral Medical Inc. Announces Change to Auditor
GlobeNewswire
Spectral Medical Provides June Tigris Trial Update
GlobeNewswire
Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders
GlobeNewswire
Spectral Medical Inc. Announces Closing of Approximately C$8.5 Million Convertible Notes Financing
GlobeNewswire
Spectral Medical Announces First Quarter Results and Provides Corporate Update
GlobeNewswire
Spectral Medical Inc. Announces C$8.5 Million Bought Deal Convertible Note Financing
GlobeNewswire
Spectral Medical Provides April Tigris Trial Update
AI-generated - The Globe and Mail
Spectral Medical: Top 10 Undervalued Medical Diagnostics & Research Industry Stocks (EDT)
GlobeNewswire
Spectral Medical Provides Tigris Trial Update
GlobeNewswire
Spectral Medical Chair to Retire From the Board of Directors
GlobeNewswire
Spectral Medical Announces Fourth Quarter and Fiscal 2023 Results and Provides Corporate Update
GlobeNewswire
Spectral Medical Provides February Tigris Trial Update
GlobeNewswire
Spectral Medical Announces Amendment and Extension of Exclusive Supply and Distribution Agreement With Baxter Healthcare Corporation
GlobeNewswire
Spectral Medical Announces Major Milestone by Reaching Its Interim Enrollment Target of 90 Patients

Profile

Spectral Medical Inc is focused on the development and commercialization of a treatment for septic shock utilizing its endotoxin activity assay (EAA) diagnostic and the Toraymyxin therapeutic. The company also manufactures and sells proprietary reagents. The product line of the company consists of proprietary biochemical, EAA, and instrumentation.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.